Nearly all MEN2 cases are caused by germline gain of function mutations of the REarranged during Transfection (RET) proto-oncogene, with the exception of two families having germline mutations in ESR2 or MET gene that are predisposed to MTC (2, 6, 7). Here, RET is linked to medullary thyroid gland carcinoma.